Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association

Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association

Cardiometabolic Syndrome: A Package Deal

Cardiometabolic syndrome, also known as “metabolic syndrome,” refers to a constellation of metabolic abnormalities and cardiovascular risk factors clustered in a given patient. The definitions…

Inflammation in Obesity and Cardiovascular Disease

Obesity is a chronic, relapsing, heterogenous disease characterized by impaired energy regulation and inflammation that leads to cardiometabolic, biomechanical, and psychosocial health consequences. The prevalence…

Lp(a) Screening for Individuals at High ASCVD Risk

Adulting: Guidance for Transitioning Patients from Pediatric to Adult Lipid Clinics

The assumption is that patients can engage in self-care and can navigate the healthcare system, thus ensuring a smooth transition. This is an extended process…

Is There a Role for Aspirin in Prevention in 2022?

With recent guideline changes, it is common for clinicians to field questions regarding aspirin therapy. This article is intended to help clinicians apply an individualized…

Case Study: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obesity

Incretins are hormones secreted by intestinal cells in response to the ingestion of glucose and other nutrients. These hormones stimulate pancreatic β cells to secrete…

AHA Scientific Statement on Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) contributes to cardiovascular disease risk through dyslipidemia, insulin resistance, altered coagulation states, and increased inflammation. NAFLD occurs in greater than…